Maria Verissimo, MSc,  —

Recent Posts

• Phase 1b trial enrolling to test continuous low-dose lenalidomide
• Aphexda approved in US to improve autologous stem cell transplants
• Some myeloma cells may mutate to resist T-cell therapies: Study
• Spotlight shines on blood cancer this September awareness month
• Elranatamab, now Elrexfio, approved for hard-to-treat myeloma